T0	Outcomes 77 87	recurrence
T1	Outcomes 377 387	Recurrence
T2	Outcomes 505 546	immunosuppression in large genital warts.
T3	Outcomes 670 692	recurrence of large CA
T4	Outcomes 898 915	recurred lesions.
T5	Outcomes 971 991	patients' Treg cells
T6	Outcomes 1005 1050	function of HPV-specific T cells and NK cells
T7	Outcomes 1094 1126	immune milieu of the lesion site
T8	Outcomes 1143 1174	elimination of remnant viruses.
T9	Outcomes 1287 1303	treatment of CA.